Cartilage Oligomeric Matrix Protein, COMP may be a Better Prognostic Marker Than CEACAM5 and Correlates With Colon Cancer Molecular Subtypes, Tumor Aggressiveness and Overall Survival.

Wusterbarth, Emily; Chen, Yuliang; Jecius, Hunter; Krall, Erika; Runyan, Raymond B; Pandey, Ritu; Nfonsam, Valentine

Wusterbarth, Emily; Chen, Yuliang; Jecius, Hunter; Krall, Erika; Runyan, Raymond B; Pandey, Ritu; Nfonsam, Valentine.

Afiliación

Wusterbarth E; Department of Surgery, University of Arizona Medical Center, Tucson, Arizona.
Chen Y; University of Arizona Cancer Center, Tucson, Arizona.
Jecius H; Department of Surgery, University of Arizona Medical Center, Tucson, Arizona.
Krall E; Department of Surgery, University of Arizona Medical Center, Tucson, Arizona.
Runyan RB; Department of Cellular and Molecular Medicine, University of Arizona Medical Center, Tucson, Arizona.
Pandey R; University of Arizona Cancer Center, Tucson, Arizona; Department of Cellular and Molecular Medicine, University of Arizona Medical Center, Tucson, Arizona.
Nfonsam V; Department of Surgery, University of Arizona Medical Center, Tucson, Arizona. Electronic address: vnfonsam@surgery.arizona.edu.

J Surg Res ; 270: 169-177, 2022 02.

Article en En | MEDLINE | ID: mdl-34687957

Asunto(s)

Neoplasias del Colon; Biomarcadores de Tumor/genética; Antígeno Carcinoembrionario; Proteína de la Matriz Oligomérica del Cartílago/genética; Moléculas de Adhesión Celular; Neoplasias del Colon/patología; Proteínas Ligadas a GPI/genética; Humanos; Pronóstico

Palabras clave

CEACAM5; COMP; Cartilage oligomeric matrix protein; Colon cancer; Consensus molecular subtypes; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Colon Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Surg Res Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google